IgM nephropathy in a patient with dermatomyositis following COVID-19 vaccination: A case report
Description
CONCLUSION: We describe the first case of IgM nephropathy in a DM patient following COVID-19 vaccination. This phenomenon requires further investigation into the possible crosslinks between the pathogenesis of IgM nephropathy with DM and the COVID-19
